Naji Peyman, Kumar Geetika, Dewani Shabana, Diedrich William A, Gupta Ankur
Department of Internal Medicine, Dayton Veterans Affair Medical Center, Boonshoft School of Medicine, Wright State University, 4100 West Third Street, Dayton, OH 45428, USA.
Case Rep Med. 2013;2013:194542. doi: 10.1155/2013/194542. Epub 2013 Nov 11.
Graves' disease (GD) is associated with various hematologic abnormalities but pancytopenia and autoimmune hemolytic anemia (AIHA) are reported very rarely. Herein, we report a patient with GD who had both of these rare complications at different time intervals, along with a review of the related literature. The patient was a 70-year-old man who, during a hospitalization, was also noted to have pancytopenia and elevated thyroid hormone levels. Complete hematologic workup was unremarkable and his pancytopenia was attributed to hyperthyroidism. He was started on methimazole but unfortunately did not return for followup and stopped methimazole after a few weeks. A year later, he presented with fatigue and weight loss. Labs showed hyperthyroidism and isolated anemia (hemoglobin 7 g/dL). He had positive direct Coombs test and elevated reticulocyte index. He was diagnosed with AIHA and started on glucocorticoids. GD was confirmed with elevated levels of thyroid stimulating immunoglobulins and thyroid uptake and scan. He was treated with methimazole and radioactive iodine ablation. His hemoglobin improved to 10.7 g/dL at discharge without blood transfusion. Graves' disease should be considered in the differential diagnosis of hematologic abnormalities. These abnormalities in the setting of GD generally respond well to antithyroid treatment.
格雷夫斯病(GD)与多种血液学异常有关,但全血细胞减少症和自身免疫性溶血性贫血(AIHA)的报道极为罕见。在此,我们报告一名患有GD的患者,他在不同时间间隔出现了这两种罕见并发症,并对相关文献进行了综述。该患者为一名70岁男性,住院期间还被发现患有全血细胞减少症且甲状腺激素水平升高。全面的血液学检查无异常,其全血细胞减少症归因于甲状腺功能亢进。他开始服用甲巯咪唑,但遗憾的是未进行随访,几周后便停用了甲巯咪唑。一年后,他出现疲劳和体重减轻。实验室检查显示甲状腺功能亢进和单纯性贫血(血红蛋白7g/dL)。他的直接抗人球蛋白试验呈阳性,网织红细胞指数升高。他被诊断为AIHA,并开始使用糖皮质激素治疗。甲状腺刺激免疫球蛋白水平升高以及甲状腺摄取和扫描结果证实了GD的诊断。他接受了甲巯咪唑和放射性碘消融治疗。出院时,他的血红蛋白升至10.7g/dL,未进行输血。在血液学异常的鉴别诊断中应考虑格雷夫斯病。GD情况下的这些异常通常对抗甲状腺治疗反应良好。